Hemostemix Inc.
HMTXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14 | $18 | $7 | $9 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $5 | $5 | $5 |
| Enterprise Value | $16 | $22 | $11 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.002 | -0.014 | -0.024 |
| % Growth | -14.3% | 84.4% | 44.2% | – |
| Operating Cash Flow | -$2 | -$1 | $0 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | $0 | -$2 |